Clinical Trials on Acute Adenoviral Conjunctivitis

Total 16826 results

Bausch & Lomb Incorporated

Completed

Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy Volunteers

Allergic Conjunctivitis
ORA, Inc.

Completed

Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model

Allergic Conjunctivitis

United States
Realm Therapeutics, Inc.

Completed

Effectiveness of PR013 Topical Ophthalmic Drops Compared to Vehicle for the Treatment of Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Laboratorios Sophia S.A de C.V.

Withdrawn

Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis

Allergic Conjunctivitis
Alcon Research

Completed

Mast-Cell Stabilizing Effects of Olopatadine

Allergic Conjunctivitis

Italy
Vistakon Pharmaceuticals

Completed

Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers

Allergic Conjunctivitis

United States
Alcon Research

Completed

Safety and Comfort of AL-4943A Ophthalmic Solution

Allergic Conjunctivitis
Santen Pharmaceutical Co., Ltd.

Completed

Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis

Allergic Conjunctivitis

Japan
Bausch & Lomb Incorporated

Completed

Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Vistakon Pharmaceuticals

Completed

Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Hom, Milton M., OD, FAAO
Allergan

Unknown

Comparison of Tolerability Between Two Allergy Drops

Allergic Conjunctivitis

United States
Hom, Milton M., OD, FAAO
Merck Sharp & Dohme LLC

Withdrawn

Comparison of CL Wear Between Two Allergy Drops

Allergic Conjunctivitis
Bausch & Lomb Incorporated

Completed

Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution

Allergic Conjunctivitis

United States
Faes Farma, S.A.
ORA, Inc.

Completed

A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model

Allergic Conjunctivitis

United States
Faes Farma, S.A.
Dynamic Science S.L.

Completed

Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in Children

Allergic Conjunctivitis

Spain
Aldeyra Therapeutics, Inc.

Completed

The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis.

Allergic Conjunctivitis

Canada
Alyatec

Completed

Clinical Validation Study in Allergic Conjunctivitis to Birch Pollen During Allergen Challenge in ALYATEC EEC

Allergic Conjunctivitis

France
Aldeyra Therapeutics, Inc.

Completed

A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Bausch & Lomb Incorporated

Completed

Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients

Allergic Conjunctivitis

United States
Southern California College of Optometry at Marshall...

Completed

Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Sun Yat-sen University

Unknown

China Red Eye Study on Allergic Conjunctivitis

Allergic Conjunctivitis

China
Alcon Research

Completed

Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects

Allergic Conjunctivitis
Koffler Vision Group
Fera Pharmaceuticals, LLC

Terminated

Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Alcon Research

Completed

Patient Perception Study for AL-4943A

Allergic Conjunctivitis

Korea, Republic of
Sun Pharma Advanced Research Company Limited

Completed

Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Vistakon Pharmaceuticals

Completed

Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers

Allergic Conjunctivitis

United States
Vistakon Pharmaceuticals

Completed

Safety and Efficacy Study of a Eye Drop for Eye Allergy

Allergic Conjunctivitis

United States
Santen Pharmaceutical Co., Ltd.

Completed

A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis

Allergic Conjunctivitis

Japan
Alcon Research

Completed

Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Allergan

Completed

AGN-229666 for the Treatment of Allergic Conjunctivitis

Allergic Conjunctivitis

Japan
Alcon Research

Completed

Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model

Allergic Conjunctivitis
Bausch & Lomb Incorporated

Completed

Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers

Allergic Conjunctivitis
Hom, Milton M., OD, FAAO
Bausch & Lomb Incorporated

Unknown

Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses

Allergic Conjunctivitis
Meiji University of Oriental Medicine
Kyoto Prefectural University of Medicine

Terminated

Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan

Allergic Conjunctivitis

Japan
Telios Pharma, Inc.

Recruiting

A Study Of TL-925 For The Treatment of AC

Allergic Conjunctivitis

United States
Telios Pharma, Inc.

Recruiting

A Study of TL-925 for the Treatment of Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Noveome Biotherapeutics, formerly Stemnion

Completed

Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Faes Farma, S.A.
ORA, Inc.

Completed

A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.

Allergic Conjunctivitis

United States
Ocular Therapeutix, Inc.

Completed

A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Shire

Completed

Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis

Allergic Conjunctivitis

United States
ORA, Inc.

Completed

Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model

Allergic Conjunctivitis

United States
Aciex Therapeutics, Inc.

Completed

Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model

Allergic Conjunctivitis

United States
Aciex Therapeutics, Inc.

Completed

Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model (AC-170)

Allergic Conjunctivitis

United States
Alcon Research

Completed

Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis

Allergic Conjunctivitis
Cunningham, Derek N., O.D., P.A.
Bausch & Lomb Incorporated

Completed

A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft

Allergic Conjunctivitis

United States
Alcon Research

Completed

Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan

Allergic Conjunctivitis
Alcon Research

Completed

Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients

Allergic Conjunctivitis

Japan
Bausch & Lomb Incorporated

Withdrawn

A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis

Allergic Conjunctivitis
Alcon Research

Completed

Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients

Allergic Conjunctivitis

United States
Alcon Research

Completed

An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic Conjunctivitis

Allergic Conjunctivitis

Japan

3

Subscribe